Author

S. E. Degn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

L. Jensen· 2 shared A. B. Rovsing· 1 shared A. D. Papanastasiou· 1 shared A. J. Howarth· 1 shared B. Hansen· 1 shared C. S. Larsen· 1 shared E. K. Axelgaard· 1 shared E. Perouzel· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L. Jensen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A minimal two-residue C-terminal truncation of AID in adult-onset hyper-IgM syndrome type 2 (HIGM2)

K. Green, A. B. Rovsing, E. Terczynska-Dyla, L. Jensen, K. Machalica, J. H. Wolff, L. Westerberg, C. S. Larsen, L. Lin, J. G. Mikkelsen, J. M. B. Jensen, S. E. Degn

This study identifies a two-residue C-terminal truncation variant in AID causing adult-onset HIGM2 and shows it disrupts CSR and SHM.

bioRxiv · Nov 2, 2026 · PreprintImmunology

STING activation counters glioblastoma by vascular alteration and immune surveillance

J. V. Joseph, M. S. Blaavand, H. K. Cai, F. Vernejoul, R. W. Knopper, T. B. Lindhardt, K. K. Skipper, E. K. Axelgaard, L. K. Reinert, J. G. Giehm Mikkelsen, P. Borghammer, S. E. Degn, E. Perouzel, H. Hager, B. Hansen, , M. K. Thomsen

This study shows that STING activation reduces glioblastoma progression and prolongs survival by altering tumor vasculature and enhancing immune surveillance.

bioRxiv · Sep 3, 2023Cancer Biology

Extrafollicular responses are sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus

L. F. Voss, A. J. Howarth, T. R. Wittenborn, S. Hummelgaard, K. Juul-Madsen, K. S. Kastberg, M. K. Pedersen, L. Jensen, A. D. Papanastasiou, T. Vorup-Jensen, K. Weyer, S. E. Degn

This study shows that blocking germinal centers does not prevent lupus progression and instead accelerates extrafollicular autoimmunity.

bioRxiv · Mar 4, 2022Immunology